Premium
This is an archive article published on August 15, 2022

Serum Institue of India’s Poonawalla expects Omicron-specific vaccine in 6 months: Report

SII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield.

Serum Institute of India's Chief Executive Officer Adar Poonawalla (File Photo)Serum Institute of India's Chief Executive Officer Adar Poonawalla (File Photo)

Serum Institute of India’s (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, NDTV reported on Monday.

SII, the world’s biggest vaccine maker, produces AstraZeneca’s COVID-19 vaccine under the brand name Covishield.

SII did not immediately respond to a Reuters request for comment.

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Loading Taboola...
Advertisement